# Citrus Bergamot LDL Cholesterol Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/citrus-bergamot-ldl-cholesterol-meta-analysis-evidence-review
Category: evidence-review
Summary: Citrus Bergamot LDL Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa
Last reviewed: 2026-07-28
Reviewed by: Migaku Evidence Review
# Citrus Bergamot LDL Cholesterol Meta-analysis: What the Evidence Says

## Quick Answer

Citrus Bergamot LDL Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Green Recovery of Bioactive Compounds from Bergamot ( Citrus bergamia ) By-Products: Sustainable Extraction, Food Applications, and Health-Promoting Properties | narrative review | 3 | 2026-06-01 | 10.3390/foods15111955 |
| Functional Foods for Cholesterol Management: A Review of the Mechanisms, Efficacy, and a Novel Cholesterol-Lowering Capacity Index | narrative review | 3 | 2025-08-15 | 10.3390/nu17162648 |

## What The Sources Report

- In addition to its essential oil, bergamot is a relevant source of polyphenols and flavonoids, including unique C-glycosyl flavonoids such as brutieridin and melitidin, which have been associated with cardiometabolic, antioxidant, and anti-inflammatory effects. [De Bruno Alessandra (2026); evidence level 3]
- Currently, most industrial residues are mainly destined for livestock feed or bioenergy production, despite evidence showing that bergamot pomace and peel-derived fractions exhibit high phenolic content and strong antioxidant activity, as assessed by commonly used spectrophotometric assays such as DPPH, ABTS, and FRAP. [De Bruno Alessandra (2026); evidence level 3]
- Hypercholesterolemia (high blood cholesterol) is a well-established risk factor for atherosclerosis and cardiovascular disease (CVD). [Jacobo-Velázquez Daniel A. (2025); evidence level 3]
- Epidemiological data have shown that lowering LDL cholesterol produces a proportional reduction in CVD risk. [Jacobo-Velázquez Daniel A. (2025); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For citrus bergamot LDL cholesterol meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- De Bruno Alessandra (2026). Green Recovery of Bioactive Compounds from Bergamot ( Citrus bergamia ) By-Products: Sustainable Extraction, Food Applications, and Health-Promoting Properties. DOI: 10.3390/foods15111955. PMCID: PMC13256202. PMID: 42279740. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13256202/
- Jacobo-Velázquez Daniel A. (2025). Functional Foods for Cholesterol Management: A Review of the Mechanisms, Efficacy, and a Novel Cholesterol-Lowering Capacity Index. DOI: 10.3390/nu17162648. PMCID: PMC12389712. PMID: 40871675. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12389712/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.